Beyond barrier immunity: IL-17 safeguards the renal epithelium
Journal of Experimental Medicine · 07.09.2026 · 223 (9)
DOI: 10.1084/jem.20261148 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Experimental Medicine, online erschienen am 21.07.2026. Verfasst von Michail S Lionakis. Beteiligte Einrichtung: Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID)…. Hauptthemen laut MEDLINE: Interleukin-17, Kidney, Candidiasis. Die Arbeit nennt 16 Literaturangaben. Gefördert von: NIH HHS, U.S. Department of Health and Human Services, National Institutes of Health.
Abstract (Originalsprache)
IL-17 is well-recognized for orchestrating mucosal antifungal immunity. In this issue of JEM, Choi et al. (https://doi.org/10.1084/jem.20260530) identify a downstream tPA–LRP1 axis that safeguards the renal epithelium during systemic candidiasis, revealing a mechanism by which IL-17 preserves organ integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
ORCID-Profile: Michail S Lionakis
Förderung
- NIH HHS
- U.S. Department of Health and Human Services
- National Institutes of Health
Zitieren
APA
Lionakis, M. S. (2026). Beyond barrier immunity: IL-17 safeguards the renal epithelium. Journal of Experimental Medicine, 223(9). https://doi.org/10.1084/jem.20261148
Vancouver
Lionakis MS. Beyond barrier immunity: IL-17 safeguards the renal epithelium. Journal of Experimental Medicine. 2026;223(9). doi:10.1084/jem.20261148
BibTeX
@article{Lionakis2026,
author = {Lionakis, Michail S},
title = {Beyond barrier immunity: IL-17 safeguards the renal epithelium},
journal = {Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {9},
doi = {10.1084/jem.20261148}
}
EUVIMED